The purpose of this study is to investigate the effect of inflammatory status on metabolic abnormalities in hypertensive patients. A cross-sectional study involved 106 hypertensive patients. Interview questionnaire was used to collect personal information and lifestyle habits. Participants who suffered from acute or chronic inflammatory diseases or continue using medicines were excluded as it might affect the biomedical results. Patients were categorized into two groups based on the inflammatory status: desirable inflammatory status (DIS) (CRP ˂ 3 mg/L) and undesirable inflammatory status (UIS) (CRP ≥ 3 mg/L). All patients had a stable weight with no fluctuations > 2% of their body weight for at least 2 months prior to the study. UIS condition is associated with women and older patients. The prevalence of UIS decreased significantly as the intensity of physical activity increased, while no effect was detected due to differencing smoking habits. For anthropometric measurements, UIS patients were higher in body mass index (33.4 ± 7.06 vs. 24.8 ± 10.7 kg/m 2 , P ˂ 0.001) and overall waist circumference (112.0 ± 12 vs. 105.0 ± 19 cm, P = 0.006). The gender-adjusted difference of the waist circumference revealed that UIS patients were higher among men (105.0 ± 19 vs. 114.55 ± 14 cm, P = 0.004), while there no significant difference observed among women patients. The differences of metabolic markers explained that UIS patients were higher in fasting blood glucose, total cholesterol, and triglyceride (106.0 ± 34 vs. 95.5 ± 26 mg/dL, P = 0.025; 191.0 ± 57 vs. 173.0 ± 49 mg/dL, P = 0.017; 151.5 ± 110 vs. 123.0 ± 58 mg/dL, P = 0.002; respectively). In addition, UIS patients were higher on interleukin 6 and lower on adiponectin (2.32 ± 0.80 vs. 1.40 ± 0.75 pg/ mL, P ˂ 0.001; 11.15 ± 4.5 vs. 13.5 ± 5.3 mg/L, P = 0.01; respectively), while the differences in systolic and diastolic blood pressure did not reach the level of significance. Hypertensive patients of UIS have significant risks to develop metabolic abnormalities and progress to metabolic syndrome. Managed inflammation and lifestyle habits could reduce the risk of developing metabolic abnormalities in hypertensive patients.
Introduction
Hypertension (HT) is a condition of elevated systolic blood pressure (SBP) more than 140 mmHg and/or diastolic blood pressure (DBP) more than 90 mmHg, or the use of antihypertensive medications [1] . It is ranked as the third most important risk factor for attributable burden of disease in South Asia in 2010 [2] . The World Health Organization (WHO) rates HT as one of the most important causes of premature death worldwide [3] . HT is also one of the most important preventable causes of death worldwide and one of the common conditions treated in the primary care in the UK, where it affects more than a quarter of all adults and over a half of those are over the age of 65 years old [4] .
In 2005, about 20.6% of men and 20.9% of women in India have suffered from HT, and these percentages will increase for about 22 .9% and 23.6% for men and women respectively by 2025 [5] . Among the population in Hong Kong territories, self-reported HT has risen to 9.82% and 11.58% in 2008 compared to 7.96% and 10.0% in 2005 for male and female, respectively [6] . A very little evidence about blood pressure (BP) survey has been collected from ten Arab countries. The overall estimated prevalence of HT is 29.5%, which indicates a higher prevalence of HT among Arabs compared to people from the USA (28%) and sub-Saharan African (27.6%) [7] . In Saudi Arabia, the overall prevalence of HT among Saudis is 15.2% of adults, and about 40.6% of the overall adults are at the borderline of hypertension [8] . In Palestine, the prevalence of obesity and the consequences of non-communicable diseases (NCDs) have escalated in recent years in both urban and rural areas [9] . Uncontrolled HT has been considered the main risk factor in developing metabolic syndrome for both male and female Palestinian adults [10] .
In addition to metabolic syndrome, uncontrolled HT has been associated with stroke, left ventricular hypertrophy, nephropathy, retinopathy, ischemic heart disease, and peripheral vascular disease [11] . Inflammation has also been associated with major adverse cardiovascular events [12] , atherosclerosis and aortic stiffness [13] , metabolic syndrome [14] , and blood pressure (BP) [15, 16] . Since inflammation has been associated with BP increment, the riser group has clear inflammatory status compared to dipper group [17] in both obese and nonobese patients [18] . After establishing the multivariate analysis, inflammation evidenced by C-reactive protein (CRP) is found to be the prominent risk factor for elevated BP [19] , and the increase of CRP is associated with the increase of HT among non-diabetic population [20] . Moreover, after the categorization of Asian Indians into four groups (diseased obese, healthy obese, diseased non-obese, and healthy nonobese), inflammation is observed clearly in diseased groups compared to non-diseased groups [21] . Therefore, the purpose of this study is to investigate the effect of inflammatory status on metabolic abnormalities in hypertensive patients.
Materials and Methods

Patients and Study Design
A cross-sectional study was conducted involving 106 hypertensive patients out of 484 subjects screened, between 30 and 60 years of age. Patients' enrolment was continued for 7 months from November 2013 to May 2014 via cluster random sampling at seven centers of primary health care departments under the Ministry of Health in Gaza, Palestine. The study was ethically approved by Helsinki Committee for Ethical Approval of Gaza (Number: PHRC/HC/11/13). All patients had a stable weight with no fluctuations > 2% of their body weight for at least 2 months prior to the study. All patients have managed their HT by enalapril maleate 10 mg (twice daily). Patients who have suffered conditions like diabetes, cancers, heart disease, liver and renal diseases, pregnancy, or used medicines regularly like NSAIDs and statin were excluded as it might affect the laboratory results. Patients were grouped into two groups according to the inflammatory status; the first group was the desirable inflammatory status group (DIS) with CRP ˂3 mg/L, while the second group was the undesirable inflammatory status group (UIS) with CRP ≥ 3 mg/L. The grouping of inflammatory status depended on the recommendation of American Heart Association and Center for Disease Control and Prevention (AHA/CDC) [22] .
Interview Questionnaire
The information regarding the patients' characteristics and lifestyle factors were collected after the informed consent was given. Patients' characteristics factors included age, gender, health/disease history, and medicine usage. Lifestyle factors involved smoking habits and physical activity pattern. The smoking habits were assessed according to the modified form of The Behavioral Risk Factor Surveillance System that has been approved by Centers for Disease Control and Prevention (CDC) Survey Data [23] . Patients have been categorized into one of the two smoking habits as the following; current smokers that included active and passive smokers or non-smokers that included past smokers and never smokers. The patient considered as smoker if being smoker irrespective on the number of cigarette daily and duration of smoking. The patient considered as passive smoker if patient was closely in contact with smokers for more than 1 h weekly. As well, patient has been considered as a past smoker if smoked more than 100 cigarettes in the past or stopped the smoking for at least 1 year. If the patient did not reach any of past criteria, the patient was known as never smokers. Additionally, physical activity pattern was evaluated according to the Global Physical Activity Questionnaire (GPAQ) Version-2 which considers the Palestinian specifications [24] .
Anthropometric Measurements
Seca Stadiometer was used to assess BMI. BMI was calculated by using height and weight based on the formula (BMI (kg/ m 2 ) = weight (kg) / height (m 2 )) [25] . Seca 201 non-elastic tape was used to assess waist circumference (WC) according to the National Institute of Health recommendation. The measurement was taken at the level of the superior border of the iliac crest and parallel to the floor [26, 27] .
Biomedical Data
Quantitative methods were used to assess fasting blood glucose (FBG), total cholesterol (TC), triglyceride (TG), and high sensitivity C-reactive protein (CRP) via Mindray® BS-120 Chemistry Auto-analyzer. CRP turbidimetric latex 1:5 kit was used to assess CRP. Enzymatic colorimetric method with glucose oxidase was used to estimate FBG. Commercial kits were used to assess TC and TG. Sigma-Aldrich® ELISA kits via ELISA Reader was used to assess IL-6 and adiponectin. BP was determined by using validated and standard mercury sphygmomanometer, where SBP was defined as the appearance of the first sound (Korotkoff phase 1) and DBP was the disappearance of the sound (Korotkoff phase 5) during the deflation of the cuff at 2-3 mmHg/s reduction rate of mercury column. Seven milliliters of blood (into two tubes) were drawn into a polyethylene evacuated tube. One tube was used to evaluate the quantitative measures CRP, FBG, TC, and TG, and the other tube was stored at − 80°C after the separation of serum to analyze IL-6 and adiponectin via one-run ELISA.
Statistical Analyses
Data was analyzed by using the Statistical Package for the Social Sciences version 21.0 software (SPSS Inc., Chicago, IL, USA). Descriptive statistics including frequencies and percentages represented the patients' characteristics. Central tendency of continuous variables was presented by median ± interquartile range (IQR). Chi-square (χ 2 ) was used to compare the categorical variables, and Mann-Whitney U test was used to evaluate the differences of continuous variables. P value of ≤ 0.05 was considered statistically significant and the level of confidence was 95%.
Results
A total of 106 hypertensive patients were enrolled in the study to identify the differences of biomedical data including metabolic and inflammatory indicators according to the differenced inflammatory status. The indices of BMI and WC were used as the measurements for anthropometric characteristics. Table 1 describes the baseline characteristics of participants. The study involved 60 (56.6%) women and 46 (43.4%) men. Patients were grouped according to age in which patients more than 50 years of age were 54 (50.9%) and less than or equal 50 years were 52 (49.1%). Concerning smoking habits, there were two groups; current smokers involving active and passive smokers (49 patients, 46.2%) and non-smokers involving past smokers and never smoke (57 patients, 53.8%). According to physical activity pattern, 65 (52.8%) patients were low physically active, 37 (34.9%) were moderate, and 13 (12.3%) were high physically active. By categorizing the patients according to inflammatory status, 54 (50.9%) subjects were indicated as desirable inflammatory status (DIS) (CRP˂3 mg/L) and 52 (49.1%) were indicated as undesirable inflammatory status (UIS) (CRP ≥ 3 mg/L).
The differences in participants' characteristics and biomedical data according to the differenced of inflammatory status are shown in Table 2 . The results indicated that women had a significantly higher percentage of inflammatory status compared to men (60.0% vs. 34.8%, P = 0.012). Concerning smoking habits, no significant difference was observed between current smokers and non-smokers due to the differenced inflammatory status, while significant differences were observed with varied physical activity pattern; as the intensity of physical activity increased, the inflammatory status become more desirable (P = 0.009). The age difference revealed that patients who had UIS were significantly older than DIS (53.5 ± 13 vs. 47.0 ± 16 years, P = 0.019). Concerning BMI and WC, patients with DIS were significantly lower than UIS (24.8 ± 10.7 vs. 33.4 ± 7.06 kg/m 2 , P ˂ 0.001; 105.0 ± 19 vs. 112.0 ± 12 cm, P = 0.006; respectively). As for biomedical data, there were no significant differences between DIS and UIS in SBP and DBP. On metabolic markers, FBG, TC, and TG were significantly differentiated by the differenced inflammatory status between DIS and UIS (95.5 ± 26 vs. 106.0 ± 34 mg/dL, P = 0.025; 173.0 ± 49 vs. 191.0 ± 57 mg/dL, P = 0.017; 123.0 ± 58 vs. 151.5 ± 110 mg/dL, P = 0.002; respectively). In addition, DIS was significantly lower than UIS on IL-6 and CRP (1.40 ± 0.75 vs. 2.32 ± 0.80 pg/mL, P ˂ 0.001; 1.02 ± 5.0 vs. 7.32 ± 2.0 mg/L, P ˂ 0.001; respectively), while DIS was significantly higher than UIS on adiponectin (13.5 ± 5.3 vs. 11.15 ± 4.5 mg/L, P = 0.016).
Discussion
The abnormalities of physiological and anthropometric markers majorly indicate the state of metabolic syndrome (MetS) [28] . As a global problem, about a quarter of adult population around the world suffer from MetS [29] . The [31] . The indicators of MetS including insulin resistance are evidenced by high level of FBG, dyslipidemia, central and total obesity, and a condition of inflammation or oxidative stress [28] . The increase of inflammation contributes to atherosclerosis, impaired vascular function, and major cardiovascular events [11] [12] [13] . The markers of inflammation CRP and IL-6 are used mainly to detect the early stages of cardiovascular diseases (CVDs) [32, 33] , and adiponectin which is an anti-inflammatory marker, secreted in abundance from adipose tissues of healthy subjects [34] , is currently used to predict the HT, CVDs, and MetS [35, 36] . Clinical studies have approved that systemic inflammation presented as BUIS^could play an important role in developing metabolic abnormalities in healthy or unhealthy subjects [37] [38] [39] .
Obesity develops MetS via inflammatory mechanism [32, 40] . In addition, Boura-Halfon and Zick [41] indicated that obesity is associated with insulin resistance and dyslipidemia, the important features of MetS. Obesity is associated with overexpression of proinflammatory cytokines as IL-6 and TNF-alpha and reduces the anti-inflammatory adipokine Badiponectin^ [32] . The increase of circulating IL-6 and the reduction of adiponectin trigger the liver to synthesize and release the marker of systemic inflammation CRP [42] . Furthermore, as IL-6 regulates inflammation, it also regulates the whole-body energy homeostasis and suppresses the activity of lipoprotein lipase enzyme [43] .
The present study divided hypertensive patients into two groups according to the inflammatory status; patient with CRP ˂ 3 mg/L was categorized as DIS while UIS category had CRP ≥ 3 mg/L. As shown in Table 2 , significant differences were observed between DIS and UIS in which the prevalence of female patients with UIS was significantly higher than male patients. A meta-analysis by Choi et al. [44] showed that inflammation and health complications were strongly correlated DIS desirable inflammatory status, UIS undesirable inflammatory status, BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, TC total cholesterol, TG triglyceride, IL-6 interleukin 6, CRP C-reactive protein *Difference is significant at P value ≤ 0.05 to women more than men irrespective of ethnicity groups, while obesity indices (WC and BMI) were also strongly correlated with the inflammation in women more than men in European, US, and Asian populations. Sex difference in the metabolic activities of adipose tissues could be attributed to the varied percentages of body fat from male to female [45] and the increase of IL-6 variance in obese women [46] and thus increase the production of CRP [45] . Moreover, sex difference on the association of inflammation has been attributed to leptin [47] while inflammatory mediators have been linked directly to body fat and early puberty in female [44] . Similar to sex, age is a non-modifiable factor, it differs significantly by differencing the inflammatory status; the UIS was older in age. The influence of age has been observed in the obesity indices and health condition among Palestinian population [48] . At the time clinical studies linked the inflammation with increasing of age, a strong indication came from the National Health and Nutrition Examination Survey 1999-2000 in which the indication stated that older subjects of normolipidemic obese adults had a significant increase in inflammatory status than younger subjects [49] . Similarly, Den Hertog et al. [50] found the level of inflammatory markers including CRP within older adult to be higher than those younger during the screening of early phase acute ischemic stroke patients, and Lee et al. [12] agreed the effect of age on inflammatory markers in a study done on type-2 diabetes.
In accordance with modifiable lifestyle factors, the prevalence of UIS was reduced by increasing the intensity of physical activity. Obesity was attributed mainly to energy imbalance, with an excessive input and decline energy expenditure [51] . Strohacker et al. [52] , Vepsäläinen et al. [53] , and Pitanga and Lessa [54] have approved the positive effect of the intensity of physical activity on inflammation and it was evidenced by CRP and/or IL-6 which in turn benefited the CVDs and diabetes consequences. In contrast, in the present study, inflammatory status was not affected by the differenced smoking habits and hence gave different result as evidenced by Tonstad and Cowan [55] and Khand et al. [56] . The influence of smoking disappeared due to the major female population compared to male and majority of them show nonsmoking habits compared to smokers of male population.
Obesity indices showed a significant difference between DIS and UIS in which the patients with UIS had higher BMI and WC than the patients with DIS, and these results are consistent with previous studies such as Klisic et al. [57] who found that the level of CRP was higher among obese women than normal weight postmenopausal women for both BMI and WC. Likewise, Arnardottir et al. [58] assessed the interaction between obstructive sleep apnea and obesity on CRP after categorizing the BMI into three groups: ˂ 30, 30 to ˂ 35, and ≥ 35 kg/m 2 , and CRP was distributed as the follows: 1.8, 2.6, and 4.1 mg/L (P ˂ 0.001); respectively. Likely, Thompson et al. [59] examined the distribution of CRP in Chinese population where WC associated strongly with CRP in both sexes. UIS patients showed significantly higher values compared to DIS according to the following metabolic markers: FBG, TC, and TG. These results are consistent with the previous studies that linked inflammation with hyperglycemia and dyslipidemia like in Indulekha et al. [21] and Stuveling et al. [20] . Lee et al. [12] found that the increase of CRP is associated with hyperglycemia, hypercholesterolemia, and hypertriglyceridemia significantly. Furthermore, the evidence of the present study has approved the significant increment of IL-6 and the reduction of adiponectin with UIS condition. In the context, Wannamethee et al. [60] have found a strong and significant association between IL-6 and CRP (P < 0.001) during the evaluation of risk factors associated with MetS and CVDs among overage British, while Ridker et al. [61] studied the relation between IL-6 and CRP in 202 myocardial infarction patients and 202 apparently healthy participants matched by age and sex. A significant correlation was indicated (r = 0.43, P < 0.001) and the relationship of IL-6 with subsequent risk for myocardial infarction remained after control for this factor (P < 0.001). Similarly, Connelly et al. [62] determined the predictors of CRP by regression analysis in which BMI and IL-6 were the independent determinants of CRP in female, and WC and IL-6 were the independent determinants in male. Additionally, Sedighi and Abediankenari [63] identified an inverse correlation between CRP and adiponectin in chronic kidney disease patients (r = − 0.548, P < 0.001) and Indulekha et al. [21] have found that adiponectin was reduced in Asian Indians who have elevated level of IL-6 and CRP. Finally, no differences were observed in SBP and DBP due to the differenced inflammatory status. This result might be because all of the participants were hypertensive, and similar results have been detected by Den Hertog et al. [50] who evaluated the prognostic value of CRP within 12 h of onset of ischemic stroke. The elevated CRP did not associate with high SBP and DBP (P = 0.63, P = 0.81, respectively).
Conclusion
Hypertensive patients of undesirable inflammatory status (UIS) have significant risks to develop metabolic abnormalities and progress to MetS. It was reported that UIS patients have higher WC and BMI in addition to lower physical activity. They also have higher level of metabolic markers; FBG, TC, and TG. UIS patients showed higher level of inflammatory mediator IL-6, and lower level of anti-inflammatory marker adiponectin. The constellation of undesirable biomedical data that was associated with UIS condition has proved the risks of MetS development. MetS does not have a single cause, thus controlling lifestyle habits and managing the risk factors can combat and delay the progress of metabolic abnormalities.
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